Floating Button
Home Capital Broker's Calls

DBS Research bets Covid-19 recovery hopes on Covid-19 vaccine in 2021

Ng Qi Siang
Ng Qi Siang • 5 min read
DBS Research bets Covid-19 recovery hopes on Covid-19 vaccine in 2021
Ten of the candidates are now in Phase 3 trials, with the first results coming out as soon as October.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

As Covid-19 continues to devastate the global economy, DBS Research analyst Yeo Kee Yan and his team have placed their hopes for economic recovery on the successful development of a viable vaccine. With 38 candidates now undergoing clinical evaluations, one or more positive outcomes will be the spark that will fuel ailing economies, they write in a report dated Oct 6.

“Nine months after the first Covid-19 cluster surfaced in China, the world is no closer to containing the pandemic. There are now more than 32 million confirmed cases globally and the figure is rising at a rate of 200,000 to 350,000 new cases per day,” says the team. Six months on from the “great Covid-19 pandemic panic”, how countries manage the virus continues to be a key driver for stock performances today.

See also: Seeking truth from facts in Covid-19

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.